<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Genome Res</journal-id>
<journal-id journal-id-type="iso-abbrev">Genome Res</journal-id>
<journal-id journal-id-type="hwp">genome</journal-id>
<journal-id journal-id-type="pmc">genome</journal-id>
<journal-id journal-id-type="publisher-id">GENOME</journal-id>
<journal-title-group>
<journal-title>Genome Research</journal-title>
</journal-title-group>
<issn pub-type="ppub">1088-9051</issn>
<issn pub-type="epub">1549-5469</issn>
<publisher>
<publisher-name>Cold Spring Harbor Laboratory Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27965292</article-id>
<article-id pub-id-type="pmc">5340962</article-id>
<article-id pub-id-type="medline">9509184</article-id>
<article-id pub-id-type="doi">10.1101/gr.206805.116</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Engineered LINE-1 retrotransposition in nondividing human neurons</article-title>
<alt-title alt-title-type="left-running">Macia et al.</alt-title>
<alt-title alt-title-type="right-running">LINE-1 activity is lineage-dependent in humans</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Macia</surname>
<given-names>Angela</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="author-notes" rid="FN1">10</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Widmann</surname>
<given-names>Thomas J.</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="author-notes" rid="FN2">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Heras</surname>
<given-names>Sara R.</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="author-notes" rid="FN2">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ayllon</surname>
<given-names>Veronica</given-names>
</name>
<xref ref-type="aff" rid="af2">2</xref>
<xref ref-type="author-notes" rid="FN2">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sanchez</surname>
<given-names>Laura</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="author-notes" rid="FN2">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Benkaddour-Boumzaouad</surname>
<given-names>Meriem</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="author-notes" rid="FN2">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Muñoz-Lopez</surname>
<given-names>Martin</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rubio</surname>
<given-names>Alejandro</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Amador-Cubero</surname>
<given-names>Suyapa</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Blanco-Jimenez</surname>
<given-names>Eva</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Garcia-Castro</surname>
<given-names>Javier</given-names>
</name>
<xref ref-type="aff" rid="af3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Menendez</surname>
<given-names>Pablo</given-names>
</name>
<xref ref-type="aff" rid="af2">2</xref>
<xref ref-type="aff" rid="af4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ng</surname>
<given-names>Philip</given-names>
</name>
<xref ref-type="aff" rid="af5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Muotri</surname>
<given-names>Alysson R.</given-names>
</name>
<xref ref-type="aff" rid="af6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Goodier</surname>
<given-names>John L.</given-names>
</name>
<xref ref-type="aff" rid="af7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Garcia-Perez</surname>
<given-names>Jose L.</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="aff" rid="af8">8</xref>
</contrib>
</contrib-group>
<aff id="af1"><label>1</label>Department of Genomic Medicine and Centre for Genomics and Oncology (Pfizer—University of Granada and Andalusian Regional Government), PTS Granada, 18016 Granada, Spain;</aff>
<aff id="af2"><label>2</label>Department of Oncology, GENYO, Centre for Genomics and Oncology (Pfizer—University of Granada and Andalusian Regional Government), PTS Granada, 18016 Granada, Spain;</aff>
<aff id="af3"><label>3</label>Unidad de Biotecnología Celular, ISCIII, Madrid, E-28021, Spain;</aff>
<aff id="af4"><label>4</label>Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Instituciò Catalana Recerca Estudis Avançats (ICREA), 08036 Barcelona, Spain;</aff>
<aff id="af5"><label>5</label>Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030, USA;</aff>
<aff id="af6"><label>6</label>Department of Pediatrics/Rady Children's Hospital San Diego, University of California San Diego, La Jolla, California 92093, USA;</aff>
<aff id="af7"><label>7</label>McKusick-Nathans Institute for Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA;</aff>
<aff id="af8"><label>8</label>Medical Research Council Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh EH4 2XU, United Kingdom</aff>
<author-notes>
<fn fn-type="equal" id="FN2">
<label>9</label>
<p>These authors contributed equally to this work.</p>
</fn>
<fn fn-type="present-address" id="FN1">
<label>10</label>
<p>Present address: Department of Pediatrics/Rady Children's Hospital San Diego, University of California San Diego, La Jolla, CA 92093, USA</p>
</fn>
<corresp>Corresponding authors: <email>amaciaortega@ucsd.edu</email>, <email>jose.garcia-perez@igmm.ed.ac.uk</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>3</month>
<year>2017</year>
</pub-date>
<volume>27</volume>
<issue>3</issue>
<fpage>335</fpage>
<lpage>348</lpage>
<history>
<date date-type="received">
<day>9</day>
<month>3</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>1</day>
<month>12</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>
<ext-link ext-link-type="uri" xlink:href="http://genome.cshlp.org/site/misc/terms.xhtml">© 2017 Macia et al.; Published by Cold Spring Harbor Laboratory Press</ext-link>
</copyright-statement>
<copyright-year>2017</copyright-year>
<license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
<license-p>This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see <ext-link ext-link-type="uri" xlink:href="http://genome.cshlp.org/site/misc/terms.xhtml">http://genome.cshlp.org/site/misc/terms.xhtml</ext-link>). After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="335.pdf"></self-uri>
<abstract>
<p>Half the human genome is made of transposable elements (TEs), whose ongoing activity continues to impact our genome. LINE-1 (or L1) is an autonomous non-LTR retrotransposon in the human genome, comprising 17% of its genomic mass and containing an average of 80–100 active L1s per average genome that provide a source of inter-individual variation. New LINE-1 insertions are thought to accumulate mostly during human embryogenesis. Surprisingly, the activity of L1s can further impact the somatic human brain genome. However, it is currently unknown whether L1 can retrotranspose in other somatic healthy tissues or if L1 mobilization is restricted to neuronal precursor cells (NPCs) in the human brain. Here, we took advantage of an engineered L1 retrotransposition assay to analyze L1 mobilization rates in human mesenchymal (MSCs) and hematopoietic (HSCs) somatic stem cells. Notably, we have observed that L1 expression and engineered retrotransposition is much lower in both MSCs and HSCs when compared to NPCs. Remarkably, we have further demonstrated for the first time that engineered L1s can retrotranspose efficiently in mature nondividing neuronal cells. Thus, these findings suggest that the degree of somatic mosaicism and the impact of L1 retrotransposition in the human brain is likely much higher than previously thought.</p>
</abstract>
<funding-group>
<award-group id="funding-1">
<funding-source>US Department of Defense, Breast Cancer Research Program <named-content content-type="funder-id">http://dx.doi.org/10.13039/100000005</named-content></funding-source>
<award-id>BC051386</award-id>
</award-group>
<award-group id="funding-2">
<funding-source>National Institutes of Health (NIH) <named-content content-type="funder-id">http://dx.doi.org/10.13039/100000002</named-content></funding-source>
<award-id>1R03NS087290-01</award-id>
</award-group>
<award-group id="funding-3">
<funding-source>ALS Therapy Alliance <named-content content-type="funder-id">http://dx.doi.org/10.13039/100006402</named-content></funding-source>
<award-id>2013-F-067</award-id>
</award-group>
<award-group id="funding-4">
<funding-source>Marie Curie IRG project</funding-source>
<award-id>FP7-PEOPLE-2007-4-3-IRG: SOMATIC LINE-1</award-id>
<award-id>CICE-FEDER-P09-CTS-4980</award-id>
<award-id>CICE-FEDER-P12-CTS-2256</award-id>
</award-group>
<award-group id="funding-5">
<funding-source>Plan Nacional de I+D+I 2008–2011 and 2013–2016</funding-source>
<award-id>FIS-FEDER-PI11/01489</award-id>
<award-id>FIS-FEDER-PI14/02152</award-id>
</award-group>
<award-group id="funding-6">
<funding-source>European Research Council <named-content content-type="funder-id">http://dx.doi.org/10.13039/501100000781</named-content></funding-source>
<award-id>ERC-Consolidator ERC-STG-2012-233764</award-id>
</award-group>
<award-group id="funding-7">
<funding-source>Howard Hughes Medical Institute <named-content content-type="funder-id">http://dx.doi.org/10.13039/100000011</named-content></funding-source>
<award-id>IECS-55007420</award-id>
</award-group>
<award-group id="funding-8">
<funding-source>Wellcome Trust <named-content content-type="funder-id">http://dx.doi.org/10.13039/100004440</named-content></funding-source>
<award-id>ISFF2</award-id>
</award-group>
</funding-group>
<counts>
<page-count count="14"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>